Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences Presents Additional Data Supporting Lead Product Candidate for Metastatic Melanoma at SITC 2015

BASKING RIDGE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
November 05, 2015 16:16 ET | Source: Lisata Therapeutics

Caladrius Biosciences Announces Third Quarter 2015 Financial Results and Provides Corporate Update

BASKING RIDGE, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a development...
November 02, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences to Present at Multiple Upcoming November Conferences

BASKING RIDGE, N.J., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
October 29, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences to Host Third Quarter 2015 Financial Results Conference Call on November 5 at 5:00 pm

BASKING RIDGE, N.J., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a development...
October 08, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences Announces Management and Board Changes

BASKING RIDGE, N.J., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
October 01, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences to Present at Multiple Upcoming October Conferences

BASKING RIDGE, N.J., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a cell therapy company combining an industry-leading external development and manufacturing provider...
September 30, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius to Present Data Elucidating CLBS20 Mechanism of Action

BASKING RIDGE, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a company combining a leading cell therapy service provider with a development pipeline including a...
September 24, 2015 07:36 ET | Source: Lisata Therapeutics

Caladrius Biosciences Receives Award From the National Cancer Institute

BASKING RIDGE, N.J., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. ("Caladrius" or the "Company") (NASDAQ:CLBS), a cell therapy company combining an industry-leading external...
September 22, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences and Sanford Research Establish Strategic Collaboration With Goal of Developing Major Advance in Treatment of Type 1 Diabetes

BASKING RIDGE, N.J., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. ("Caladrius" or the "Company") (NASDAQ:CLBS), a cell therapy company combining an industry-leading external...
September 10, 2015 07:30 ET | Source: Lisata Therapeutics

Caladrius to Present at Multiple Upcoming Conferences

BASKING RIDGE, N.J., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a company combining a leading cell therapy service provider with a development pipeline including a...